You are here: Industry Insights > COVID-19

News List

ModeX Therapeutics Leverages ProBioGen's Expertise for Accelerated COVID-19 Antibody Development PharmaSources
May 30, 2024
ModeX will harness the power of ProBioGen's pioneering DirectedLuck® Transposase Technology, which enables the production of high-titer, stable expression cell lines that are critical to the success of ModeX's antibody program.
A Glimpse of the Capacity and Supply of Blood Products Made in China Xiaoyaowan
February 08, 2023
Gamma globulin is the passive immunity preparation, of which the most widely used product in the clinical practice is the human immunoglobulin for intravenous injection, referred to PH4.
Synthesis technology of cepharanthine, a "specific drug" for coronavirus PharmaSources/Yuntian
May 25, 2022
Recently, cepharanthine, first discovered in China as the new drug for treating COVID-19, has recently been granted the national invention patent authorization, which has drawn great attention from inside and outside the industry.
New Improvement in Universal Vaccines and Long-acting Neutralizing Antibodies PharmaSources/Yefenghong
May 25, 2022
COVID-19 has spread rapidly since the winter of 2019, and even today, the whole world is still shrouded in its haze.
Is mRNA Vaccine the Source of Intricacies of "Mysterious Hepatitis"? PharmaSources/Yefenghong
May 23, 2022
3 years into the COVID-19 pandemic, it has had a significant impact on human health and economic development. Based on WHO statistics, as of April 22, there are approximately 497 million confirmed patients and 6.179 million deaths in the world because of
The Oral Vaccine Market and Technology David Orchard-Webb
May 12, 2022
A vaccine is a biologic that improves immunity to disease. Vaccination is considered the most effective means of controlling infectious disease-related morbidity and mortality.
Breakthrough in Research of Small Molecule Drugs against SARS-CoV-2 PharmaSources/Xiaonisha
March 21, 2022
Corona virus disease 2019 (COVID-19) caused by a novel single-stranded RNA coronavirus has swept the world. The International Committee on Taxonomy of Viruses (ICTV) named the virus SARS-CoV-2.
To Win the Fight against COVID-19 in the Future, How To Make a Breakthrough in the R&D of New Drug? PharmaSources/Professor in medical field
March 21, 2022
Recently, with the continuous evolution and spread of Novel Coronavirus variant (including Delta-related variant viruses) all over the world, the mortality rate in some areas has a tendency to increase.
Weekly Pharmaceutical News Review | PharmaSources.com (Feb. 28th to March.4th) PharmaSources.com
March 16, 2022
The most talked-about news of this week is the successful overseas marketing of Nanjing LEGN.US's CAR-T, which not only demonstrates the strength of China's innovative biologics but also eases the anxiety of Chinese innovative drug companies.
Africa Expands Vaccine Manufacturing Capacity Shem Oirere
March 08, 2022
The outbreak of COVID-19 pandemic has revived the drive by governments in Africa to expand local pharmaceutical manufacturing so as to increase access to affordable quality medicines for the continent’s 1.3 billion people.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page